WINGS+++ mHealth Program for Women with Opioid Use Disorder and Domestic Violence

Enrolling by invitation at 1 trial location
DA
CP
Overseen ByCathy Pak, MPH
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Dawn A. Goddard-Eckrich
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a new mobile program, WINGS+++, can assist women who have used non-prescription opioids and experienced domestic violence. Researchers seek to understand if the program can reduce drug use and connect women to support services for substance use, domestic violence, and PTSD (post-traumatic stress disorder). The program includes three sessions on a mobile device and connects participants with a peer navigator. Women who have used non-prescribed opioids in the last 30 days and faced serious abuse by a partner in the past year may be eligible to join.

As an unphased trial, this study offers a unique opportunity to access innovative support tools and contribute to research that could benefit others in similar situations.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on using the WINGS+++ program to help with opioid use disorder and intimate partner violence.

What prior data suggests that the WINGS+++ mHealth program is safe for women with opioid use disorder and domestic violence?

Research has shown that mobile health programs like WINGS+++ are generally easy to use. The WINGS+++ program aims to assist women who have experienced intimate partner violence and have opioid or substance use disorders. It includes several sessions on a mobile device, addressing issues like violence, stress, and drug use, and helps women find appropriate support.

No specific reports of negative effects have emerged from using mobile health programs like WINGS+++. As this trial is in its early stages, it focuses more on the program's effectiveness rather than safety. However, mobile health programs are usually safe because they provide information and support through a phone or tablet.12345

Why are researchers excited about this trial?

Researchers are excited about the WINGS+++ mHealth program because it offers a unique, tech-driven approach to supporting women dealing with opioid use disorder (OUD) and domestic violence. Unlike traditional treatments that might involve medication or in-person therapy, this program uses mobile health tools combined with peer navigation, making it accessible and potentially more engaging. The program's integration of mHealth sessions with peer support from individuals with lived experience aims to provide a holistic and relatable support system, which could enhance treatment adherence and effectiveness. This innovative blend of technology and peer support is what sets WINGS+++ apart from standard care options like medication-assisted treatments, counseling, or support groups.

What evidence suggests that the WINGS+++ mHealth program is effective for women with opioid use disorder and intimate partner violence?

Research shows that the WINGS+++ program, provided to participants in this trial, may assist women dealing with opioid addiction and those who have experienced partner violence. Studies have found that individuals facing partner violence are at risk of substance misuse. The program screens for partner violence, PTSD (post-traumatic stress disorder), and substance use, offering brief support and referrals tailored to each woman's needs. WINGS+++ also connects women with peer navigators who have had similar experiences, which can be crucial in linking them to necessary services. Although direct evidence on WINGS+++ is limited, mobile health tools and peer support have shown promise in similar contexts.23456

Who Is on the Research Team?

LG

Louisa Gilbert, PhD

Principal Investigator

Columbia University

NE

Nabila El-Bassel, PhD

Principal Investigator

Columbia University

DA

Dawn A Goddard-Eckrich, EdD

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for women in Orange County, NY who have opioid or other substance use disorders and have experienced intimate partner violence. Participants should also have symptoms of PTSD. Only 7 women will be enrolled in this early-stage study.

Inclusion Criteria

Report use of non-prescribed opioids in the past 30 days
Score positive for risk of opioid use disorder or other substance use disorder on the Drug Abuse Screening Test (DAST) with a cut-off score of 6 or higher
Report experiencing any severe psychological abuse or any physical or sexual abuse by a female or male intimate partner in the past year
See 2 more

Exclusion Criteria

I am unable to speak or understand English well enough for study activities.
I do not have major psychiatric or cognitive issues that limit my participation.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive the WINGS+++ 3-session mHealth intervention with peer navigation delivered over a 30-day period

4 weeks
3 sessions (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including post-intervention focus group and satisfaction survey

4 weeks
1 focus group (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Pre-Pilot WINGS+++

Trial Overview

The study is testing WINGS+++, a mobile program with three sessions that screens for abuse, PTSD, and drug use; offers support and referrals; and connects participants to a peer navigator. It aims to see if WINGS+++ helps reduce drug use and links women to needed services.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Pre-Pilot WINGS+++ InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dawn A. Goddard-Eckrich

Lead Sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

City University of New York

Collaborator

Trials
23
Recruited
6,000+

University of Pennsylvania

Collaborator

Trials
2,118
Recruited
45,270,000+

Citations

Pre-Pilot WINGS+++: mHealth to Improve MOUD Uptake in ...

The goal of this pre-pilot for the clinical trial is to develop a mobile health (mHealth) program called WINGS+++ that can help women with opioid use disorder ...

Intimate partner violence, substance use, and health ... - PMC

Substance misuse is common among individuals exposed to IPV, and IPV-exposed women (IPV-EW) are at-risk for transitioning from substance misuse to substance use ...

Pre-Pilot WINGS++++ in Substance-Related Disorders and Stress ...

WINGS+++ is a 3-session program on a mobile device that: Screens for intimate partner violence, PTSD, and substance use; Offers brief support and referrals ...

60 Domestic Violence Trials Near You

... (mHealth) program called WINGS+++ can help women with opioid use disorder or other substance use disorders who have experienced intimate partner violence.

Meeting the Needs of Intimate Partner Violence Survivors ...

This report presents research and policy recommendations so policymakers and practitioners can make substance use disorder treatment programs safer, more ...

WINGS+++ - Social Intervention Group - Columbia University

Women with opioid use disorder (OUD) and substance use disorders (SUDs) have high rates of intimate partner violence (IPV). IPV victimization and IPV-related ...